Showing 381 - 390 of 478
Persistent link: https://www.econbiz.de/10007036122
Persistent link: https://www.econbiz.de/10007014658
Persistent link: https://www.econbiz.de/10006977051
Persistent link: https://www.econbiz.de/10006760881
Persistent link: https://www.econbiz.de/10006764522
Persistent link: https://www.econbiz.de/10009835403
Persistent link: https://www.econbiz.de/10009163370
Persistent link: https://www.econbiz.de/10009178478
his paper reconsiders sequential Monte Carlo approaches to Bayesian inference in the light of massively parallel desktop computing capabilities now well within the reach of individual academics. It first develops an algorithm that is well suited to parallel computing in general and for which...
Persistent link: https://www.econbiz.de/10014175352
To economically evaluate a new drug or other medical innovation one must assess both the changes in costs and in benefits. Safety and efficacy matter, but so do resource costs and social benefits. This paper evaluates the effects on expenditures of the recent introduction of cimetidine, a drug...
Persistent link: https://www.econbiz.de/10014181580